Clinical Trial Results:
Estudio multicéntrico, abierto, randomizado, de doce meses de duración, sobre la seguridad, tolerabilidad y eficacia de Certican®, administrado junto a un antagonista del receptor IL-2, corticoesteroides y dos niveles de exposición diferentes de tacrolimus, en pacientes con trasplante renal de novo
Summary
|
|
EudraCT number |
2005-001714-41 |
Trial protocol |
ES CZ HU PT |
Global completion date |
23 Dec 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
15 Apr 2016
|
First version publication date |
15 Apr 2016
|
Other versions |
|
Summary report(s) |
CRAD001A2426 CT.gov results public |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.